文献速递妇产影像US

早孕期子痫前期筛查的质量评估

Quality assessment of first-trimester screening for preterm pre-eclampsia.
PubMed 文献 · Ultrasound Obstet Gynecol · 2022-01-01

单中心前瞻性研究对单胎孕妇采用母体特征、平均动脉压、子宫动脉多普勒搏动指数及血清PAPP-A和PlGF进行早孕期早产子痫前期筛查,风险高于1/200者建议每日服用150 mg可溶性阿司匹林至34周;估计检出率79.7%、假阳性率16.2%,实际患病率为预期值的62%(95%CI 23-140%),研究不足以评估筛查对患病率的影响。

要点

  • 筛查模型为母体特征联合MAP、子宫动脉搏动指数、PAPP-A和PlGF,风险阈值1/200。
  • 估计检出率79.7%,假阳性率16.2%,各标志物分布与风险模型参数一致。
  • 6例早产子痫前期中4例筛查阳性,患病率为预期值的62%(95%CI 23-140%)。

核心结论

  • 单中心可在筛查人数少于2000例时评估早产子痫前期筛查性能,但评估筛查对患病率的影响需更大队列。

研究设计与样本

  • 单中心研究,前瞻性筛查单胎妊娠孕妇,采用母体特征、平均动脉压、子宫动脉多普勒搏动指数、 maternal serum PAPP-A和PlGF,基于已发表模型估算风险,风险高于1/200者建议每日150 mg可溶性阿司匹林至34周,从医院不良妊娠结局登记获取子痫前期发病信息。

诊断标准与关键数值

  • 早产子痫前期定义为37周前分娩;风险阈值高于1/200为筛查阳性;估计检出率79.7%,假阳性率16.2%;6例早产子痫前期中4例为筛查阳性;患病率为预期值的62%(95%CI 23-140%)。

临床应用与阅片要点

  • 原文未据此给出推荐。

局限性

  • 研究为单中心。
  • 筛查人数少于2000例。
  • 患病率95%CI为23-140%,研究不足以评估筛查对患病率的影响,需更大队列。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To assess the performance and impact of first-trimester preterm pre-eclampsia screening in a single center.

METHODS: This was a single-center study of women with a singleton pregnancy who were screened prospectively for preterm pre-eclampsia (i.e. delivery before 37 weeks' gestation) using maternal characteristics, mean arterial pressure (MAP), uterine artery Doppler pulsatility index, maternal serum pregnancy-associated plasma protein-A and placental growth factor. The individual risk for preterm pre-eclampsia was estimated from a published model, and those with a risk above 1 in 200 were recommended to take 150 mg soluble aspirin per day until 34 weeks. Information on the incidence of pre-eclampsia was obtained from the hospital register of adverse pregnancy outcomes. Screening performance indicators, including detection and false-positive rates, were estimated from the distribution of risks. Screening impact was estimated by dividing the observed prevalence by the expected prevalence, which was derived from the distribution of risks.

RESULTS: The distributions of MAP, uterine artery Doppler pulsatility index and serum markers were consistent with the risk model parameters. The estimated detection and false-positive rates were 79.7% and 16.2%, respectively. There were six cases of preterm pre-eclampsia, four of which occurred in women with a positive screening result. The prevalence was 62% of that expected, but the 95% CI of 23-140% indicated that the study was underpowered to assess the impact.

CONCLUSIONS: This study demonstrates that the performance of preterm pre-eclampsia screening can be estimated in a single center with fewer than 2000 women screened. However, in order to assess the impact of screening on the prevalence of the condition, a much larger cohort is needed. © 2022 International Society of Ultrasound in Obstetrics and Gynecology.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Dhaifalah I, Magalova E, Studnykova D, et al. Quality assessment of first-trimester screening for preterm pre-eclampsia. Ultrasound Obstet Gynecol. 2022. PMID: 35633510. doi:10.1002/uog.24956

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。